The goal of this challenge is to advance techniques for the prognosis and treatment of brain tumors by asking participants to develop machine learning and/or artificial intelligence models to identify biomarkers and predict patient outcomes using gene expression, DNA copy number, and clinical data. For more information and to get started, visit https://go.usa.gov/xpD4q!
-
-
Thanks so much for providing individuals with a very wonderful chance to read critical reviews from this website. It’s always very enjoyable and also jam-packed with a lot of fun for me personally and my office peers to search your site minimum thrice weekly to read through the fresh things you have got. And of course, I am also actually happy concerning the magnificent principles you give. Some 1 areas in this posting are absolutely the very best I've ever had. -
Pretty interesting! Thanks for the linkComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment